Balance of proinflammatory and antiinflammatory cytokines in mice immunized with Escherichia coli and correlation with mortality after lethal challenge

[1]  T. Standiford,et al.  Balance of inflammatory cytokines related to severity and mortality of murine sepsis , 1996, Infection and immunity.

[2]  L. Hang,et al.  Immunoregulatory cytokines modify Escherichia coli induced uroepithelial cell IL-6 and IL-8 responses. , 1996, Cytokine.

[3]  S. Dalrymple,et al.  Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection , 1996, Infection and immunity.

[4]  R. Sawyer,et al.  Interleukin-4 prevents mortality from acute but not chronic murine peritonitis and induces an accelerated tumor necrosis factor-alpha response. , 1996, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[5]  A. Keane-Myers,et al.  Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. , 1995, Journal of immunology.

[6]  T. Standiford,et al.  Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. , 1995, Journal of immunology.

[7]  T. Standiford,et al.  Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. , 1995, Journal of immunology.

[8]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[9]  H. Collins,et al.  Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection , 1995, Infection and immunity.

[10]  P. Vandenabeele,et al.  Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemia , 1994, European journal of immunology.

[11]  J. Banchereau,et al.  Interleukin 4 inhibits the production of some acute‐phase proteins by human hepatocytes in primary culture , 1993, FEBS letters.

[12]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[13]  G. Raponi,et al.  Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity , 1993, Infection and immunity.

[14]  W. Fiers,et al.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia , 1993, The Journal of experimental medicine.

[15]  G. Raponi,et al.  Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli. , 1993, The Journal of antimicrobial chemotherapy.

[16]  C. Dinarello,et al.  Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Feldmann,et al.  Interleukin 4 induces interleukin 6 production by endothelial cells: Synergy with interferon‐γ , 1991, European journal of immunology.

[18]  G. Raponi,et al.  Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria. , 1991, The Journal of infectious diseases.

[19]  S. Swisher,et al.  Interleukin‐4 Downregulates Interleukin‐6 Production in Human Peripheral Blood Mononuclear Cells , 1990, Journal of leukocyte biology.

[20]  M. Pinsky.  Multiple systems organ failure: malignant intravascular inflammation. , 1989, Critical care clinics.

[21]  E. Girardin,et al.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. , 1988, The New England journal of medicine.

[22]  E. Demaeyer,et al.  Interferons and other regulatory cytokines , 1988 .

[23]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[24]  G. Gifford,et al.  Purification and physico-chemical characterization of rabbit tumor necrosis factor. , 1980, Journal of immunology.